Product Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on February 1, 2004. The length of the article is 603 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Alnylam grants RNAx license to key patent in RNA interference.(German affiliate of Alnylam Pharmaceuticals, Inc., Ribopharma AG, grants RNAx GmbH license)Publication: BIOTECH Patent News (Newsletter)Date: February 1, 2004Publisher: Biotech Patent NewsVolume: 18 Issue: 2Distributed by Thomson Gale